相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A unified catalog of 204,938 reference genomes from the human gut microbiome
Alexandre Almeida et al.
NATURE BIOTECHNOLOGY (2021)
Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS
Alexander Queck et al.
GUT (2020)
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF
Richard Moreau et al.
JOURNAL OF HEPATOLOGY (2020)
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Agustin Albillos et al.
JOURNAL OF HEPATOLOGY (2020)
Albumin in decompensated cirrhosis: new concepts and perspectives
Mauro Bernardi et al.
GUT (2020)
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial
Elisa Pose et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Sadaf G. Sepanlou et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
Sara Vieira-Silva et al.
NATURE (2020)
Acute-on-Chronic Liver Failure
Vicente Arroyo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease
Sonja Lang et al.
GASTROENTEROLOGY (2020)
Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis
Jasmohan S. Bajaj et al.
GASTROENTEROLOGY (2020)
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
Tae Gyu Oh et al.
CELL METABOLISM (2020)
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
Jonel Trebicka et al.
JOURNAL OF HEPATOLOGY (2020)
Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis
Jasmohan S. Bajaj et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Circulating microbiome in blood of different circulatory compartments
Robert Schierwagen et al.
GUT (2019)
Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
Zhigang Ren et al.
GUT (2019)
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Maurizio Parola et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis
Javier Fernandez et al.
GASTROENTEROLOGY (2019)
Alcohol-associated liver disease, not hepatitis B, is the major cause of cirrhosis in Asia
Shivaram Prasad Singh et al.
JOURNAL OF HEPATOLOGY (2019)
Characterization of the circulating microbiome in acute-on-chronic liver failure associated with hepatitis B
Yi Zhang et al.
LIVER INTERNATIONAL (2019)
Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial
Jasmohan S. Bajaj et al.
HEPATOLOGY (2019)
Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation
Andrew Maltez Thomas et al.
NATURE MEDICINE (2019)
Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer
Jakob Wirbel et al.
NATURE MEDICINE (2019)
FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis
Marcel Sorribas et al.
JOURNAL OF HEPATOLOGY (2019)
Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis
Javier Fernández et al.
Clinical Gastroenterology and Hepatology (2019)
Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
Yi Duan et al.
NATURE (2019)
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Zachariah DeFilipp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide
Salvatore Piano et al.
GASTROENTEROLOGY (2019)
Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis
Jasmohan S. Bajaj et al.
GASTROENTEROLOGY (2019)
Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats With Cirrhosis
Leticia Munoz et al.
HEPATOLOGY (2019)
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe
Javier Fernandez et al.
JOURNAL OF HEPATOLOGY (2019)
Alcohol, liver disease and the gut microbiota
Jasmohan S. Bajaj
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either
Phillipp Hartmann et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2019)
Left Ventricular Longitudinal Contractility Predicts Acute-on-Chronic Liver Failure Development and Mortality After Transjugular Intrahepatic Portosystemic Shunt
Christian Jansen et al.
HEPATOLOGY COMMUNICATIONS (2019)
Compartmentalization of Immune Response and Microbial Translocation in Decompensated Cirrhosis
Camila Alvarez-Silva et al.
FRONTIERS IN IMMUNOLOGY (2019)
Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis
Jasmohan S. Bajaj et al.
JCI INSIGHT (2019)
Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis
Jonel Trebicka et al.
FRONTIERS IN IMMUNOLOGY (2019)
Fungal dysbiosis in cirrhosis
Jasmohan S. Bajaj et al.
GUT (2018)
Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis
Javier Fernandez et al.
GUT (2018)
Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial
Nina Kimer et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality
Jennifer M. Lehmann et al.
LIVER INTERNATIONAL (2018)
Diurnal variations in intestinal barrier integrity and liver pathology in mice: implications for alcohol binge
Robin M. Voigt et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2018)
The Human Gut Microbiome: From Association to Modulation
Thomas S. B. Schmidt et al.
CELL (2018)
Selective maternal seeding and environment shape the human gut microbiome
Katri Korpela et al.
GENOME RESEARCH (2018)
Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality
Christian Jansen et al.
HEPATOLOGY (2018)
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis
Puneet Puri et al.
HEPATOLOGY (2018)
Cell death markers in patients with cirrhosis and acute decompensation
Stewart Macdonald et al.
HEPATOLOGY (2018)
NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis
Jacqueline G. O'Leary et al.
HEPATOLOGY (2018)
Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort
Jasmohan S. Bajaj et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
JOURNAL OF HEPATOLOGY (2018)
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
Paolo Caraceni et al.
LANCET (2018)
The gut-liver axis and the intersection with the microbiome
Anupriya Tripathi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Periodontal therapy favorably modulates the oral-gut-hepatic axis in cirrhosis
Jasmohan S. Bajaj et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2018)
Extensive impact of non-antibiotic drugs on human gut bacteria
Lisa Maier et al.
NATURE (2018)
Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension
Dinesh Mani Tripathi et al.
GASTROENTEROLOGY (2018)
Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016
Donghee Kim et al.
GASTROENTEROLOGY (2018)
Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis
Richard Moreau et al.
GASTROENTEROLOGY (2018)
Acute Decompensation Boosts Hepatic Collagen Type III Deposition and Deteriorates Experimental and Human Cirrhosis
Michael Praktiknjo et al.
HEPATOLOGY COMMUNICATIONS (2018)
Gut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver Failure
Jonel Trebicka et al.
VISCERAL MEDICINE (2018)
Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer
Jun Yu et al.
GUT (2017)
Rifaximin Has No Effect on Hemodynamics in Decompensated Cirrhosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Nina Kimer et al.
HEPATOLOGY (2017)
Gut Microbiota and Complications of Liver Disease
Chathur Acharya et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2017)
Acute-on-chronic liver failure: an update
Ruben Hernaez et al.
GUT (2017)
Fecal Microbiota Transplant From a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial
Jasmohan S. Bajaj et al.
HEPATOLOGY (2017)
Intestinal fungi contribute to development of alcoholic liver disease
An-Ming Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Targeting the gut-liver axis in liver disease
Reiner Wiest et al.
JOURNAL OF HEPATOLOGY (2017)
Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close?
Jonel Trebicka
JOURNAL OF HEPATOLOGY (2017)
Liver Transplant Modulates Gut Microbial Dysbiosis and Cognitive Function in Cirrhosis
Jasmohan S. Bajaj et al.
LIVER TRANSPLANTATION (2017)
Accessible, curated metagenomic data through ExperimentHub
Edoardo Pasolli et al.
NATURE METHODS (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
The Human Gut Microbiome in Liver Diseases
Brian C. Davis et al.
SEMINARS IN LIVER DISEASE (2017)
Meta-analysis of gut microbiome studies identifies disease-specific and shared responses
Claire Duvallet et al.
NATURE COMMUNICATIONS (2017)
Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease
Veronika B. Dubinkina et al.
MICROBIOME (2017)
Microbiota, cirrhosis, and the emerging oral-gut-liver axis
Chathur Acharya et al.
JCI INSIGHT (2017)
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
Rohit Loomba et al.
CELL METABOLISM (2017)
Review article: the potential mechanisms of action of rifaximin in the management of inflammatory bowel diseases
R. B. Sartor
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease
M. Llopis et al.
GUT (2016)
Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans
Ron Sender et al.
CELL (2016)
Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation
Lirui Wang et al.
CELL HOST & MICROBE (2016)
Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis
Juan G. Abraldes et al.
GASTROENTEROLOGY (2016)
Gut microbiome and liver diseases
Herbert Tilg et al.
GUT (2016)
Proton Pump Inhibitors as a Risk Factor for Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis in Patients With Cirrhosis With Ascites
Gitte Dam et al.
HEPATOLOGY (2016)
Antibiotic Prophylaxis in Cirrhosis: Good and Bad
Javier Fernandez et al.
HEPATOLOGY (2016)
Systemic Inflammation in Decompensated Cirrhosis: Characterization and Role in Acute-on-Chronic Liver Failure
Joan Claria et al.
HEPATOLOGY (2016)
Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide
Eva Stein et al.
JOURNAL OF HEPATOLOGY (2016)
Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats
Maria Ubeda et al.
JOURNAL OF HEPATOLOGY (2016)
Acute-on-chronic liver failure: terminology, mechanisms and management
Shiv K. Sarin et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Treatment of Patients with Cirrhosis
Phillip S. Ge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Human Intestinal Microbiome in Health and Disease
Susan V. Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Epidemiology and Healthcare Burden of Acute-on-Chronic Liver Failure
Alina M. Allen et al.
SEMINARS IN LIVER DISEASE (2016)
Predisposing Factors in Acute-on-Chronic Liver Failure
Jon Trebicka
SEMINARS IN LIVER DISEASE (2016)
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Ron Sender et al.
PLOS BIOLOGY (2016)
Acute-on-chronic liver failure in cirrhosis
Vicente Arroyo et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Screening for liver fibrosis in the general population: a call for action
Pere Gines et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
Len Verbeke et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Gut Microbiota, Cirrhosis, and Alcohol Regulate Bile Acid Metabolism in the Gut
Jason M. Ridlon et al.
DIGESTIVE DISEASES (2015)
Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults
Yu Shi et al.
HEPATOLOGY (2015)
Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy
Jasmohan S. Bajaj et al.
HEPATOLOGY (2015)
Causes and Consequences of Portal Vein Thrombosis in 1,243 Patients With Cirrhosis: Results of a Longitudinal Study
Filipe Nery et al.
HEPATOLOGY (2015)
Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality
Yanfei Chen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial
Thierry Thevenot et al.
JOURNAL OF HEPATOLOGY (2015)
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure
Rajiv Jalan et al.
JOURNAL OF HEPATOLOGY (2015)
Decompensated cirrhosis and microbiome interpretation
Jasmohan S. Bajaj et al.
NATURE (2015)
Interplay of Matrix Stiffness and c-SRC in Hepatic Fibrosis
Jan Goertzen et al.
FRONTIERS IN PHYSIOLOGY (2015)
OPINION Antibiotics in early life and obesity
Laura M. Cox et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Colonic inflammation and secondary bile acids in alcoholic cirrhosis
Genta Kakiyama et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Probiotic VSL#3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial
Radha K. Dhiman et al.
GASTROENTEROLOGY (2014)
Posttranscriptional Changes of Serum Albumin: Clinical and Prognostic Significance in Hospitalized Patients With Cirrhosis
Marco Domenicali et al.
HEPATOLOGY (2014)
Survival in Infection-Related Acute-on-Chronic Liver Failure Is Defined by Extrahepatic Organ Failures
Jasmohan S. Bajaj et al.
HEPATOLOGY (2014)
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014
Shiv Kumar Sarin et al.
HEPATOLOGY INTERNATIONAL (2014)
Altered profile of human gut microbiome is associated with cirrhosis and its complications
Jasmohan S. Bajaj et al.
JOURNAL OF HEPATOLOGY (2014)
Alterations of the human gut microbiome in liver cirrhosis
Nan Qin et al.
NATURE (2014)
An integrated catalog of reference genes in the human gut microbiome
Junhua Li et al.
NATURE BIOTECHNOLOGY (2014)
Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2
Alastair J. O'Brien et al.
NATURE MEDICINE (2014)
Acute Binge Drinking Increases Serum Endotoxin and Bacterial DNA Levels in Healthy Individuals
Shashi Bala et al.
PLOS ONE (2014)
Role of Human Albumin in the Management of Complications of Liver Cirrhosis
Mauro Bernardi et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2014)
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
Richard Moreau et al.
GASTROENTEROLOGY (2013)
Deficiency of Intestinal Mucin-2 Ameliorates Experimental Alcoholic Liver Disease in Mice
Phillipp Hartmann et al.
HEPATOLOGY (2013)
Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis
Jiannis Vlachogiannakos et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function
Johannie Du Plessis et al.
JOURNAL OF HEPATOLOGY (2013)
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis
Thomas Reiberger et al.
JOURNAL OF HEPATOLOGY (2013)
Soluble TNF-Alpha-Receptors I Are Prognostic Markers in TIPS-Treated Patients with Cirrhosis and Portal Hypertension
Jonel Trebicka et al.
PLOS ONE (2013)
Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
Jasmohan S. Bajaj et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Colonic microbiome is altered in alcoholism
Ece A. Mutlu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Rifaximin Improves Systemic Hemodynamics and Renal Function in Patients With Alcohol-Related Cirrhosis and Ascites
Georgios N. Kalambokis et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis
Erica Villa et al.
GASTROENTEROLOGY (2012)
Spontaneous bacterial peritonitis: recent guidelines and beyond
R. Wiest et al.
GUT (2012)
Intestinal bacterial translocation in rats with cirrhosis is related to compromised paneth cell antimicrobial host defense
Zora Teltschik et al.
HEPATOLOGY (2012)
Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy
Kathrine Holte et al.
HEPATOLOGY RESEARCH (2012)
Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study
Monica Guevara et al.
JOURNAL OF HEPATOLOGY (2012)
A metagenome-wide association study of gut microbiota in type 2 diabetes
Junjie Qin et al.
NATURE (2012)
Acute endotoxemia following transjugular intrahepatic stent-shunt insertion is associated with systemic and cerebral vasodilatation with increased whole body nitric oxide production in critically ill cirrhotic patients
R. Jalan et al.
JOURNAL OF HEPATOLOGY (2011)
Inflammation 2010: New Adventures of an Old Flame
Ruslan Medzhitov
CELL (2010)
Hepatic Venous Pressure Gradient in 2010: Optimal Measurement Is Key
Andrew K. Burroughs et al.
HEPATOLOGY (2010)
A human gut microbial gene catalogue established by metagenomic sequencing
Junjie Qin et al.
NATURE (2010)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Oral Propranolol Decreases Intestinal Permeability in Patients With Cirrhosis: Another Protective Mechanism Against Bleeding?
Marco Senzolo et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
Juan G. Abraldes et al.
GASTROENTEROLOGY (2009)
Alterations in the Functional Capacity of Albumin in Patients with Decompensated Cirrhosis Is Associated with Increased Mortality
Rajiv Jalan et al.
HEPATOLOGY (2009)
beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis
Marco Senzolo et al.
LIVER INTERNATIONAL (2009)
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis
Cristina Ripoll et al.
GASTROENTEROLOGY (2007)
Albumin-binding function is reduced in patients with decompensated cirrhosis and correlates inversely with severity of liver disease assessed by model for end-stage liver disease
Sebastian Klammt et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2007)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
G D'Amico et al.
JOURNAL OF HEPATOLOGY (2006)
Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites
A Albillos et al.
LANCET (2004)
Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites
J Such et al.
HEPATOLOGY (2002)
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
M Malinchoc et al.
HEPATOLOGY (2000)
Complications of cirrhosis. I. Portal hypertension
J Bosch et al.
JOURNAL OF HEPATOLOGY (2000)
Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites
M Perez-Paramo et al.
HEPATOLOGY (2000)
分享论文
